from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2941/fadD28

LFCtreatmentdescriptionclass of inhibitor

-1.554

Amikacinug/mL Amikacintranslation

-1.561

Cap5-10ug/mL Capreomycintranslation

-1.821

Rox10-50 ug/mL Roxithromycintranslation

0.232

SM2-5 ug/mL Streptomycintranslation

-2.902

Tet5-10 ug/mL Tetracyclinetranslation

-1.865

Rif0.2-5ug/mL Rifampicintranscription

-1.545

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.317

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.083

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.589

CPZ10-50 ug/mL Chlorpromazinerespiration

0.745

Clofazimine10-13 ug/mL Clofaziminerespiration

0.180

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.252

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.930

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.824

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.303

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.839

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.108

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.638

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.077

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.635

KCN5-20 ug/mL Potassium cyaniderespiration

0.517

NaN30.2-2 mM Sodium aziderespiration

0.472

Nigericin50 uM Nigericinrespiration

0.436

TRC10-150 ug/mL Triclosanrespiration

1.349

TRZ10-25 ug/mL Thioridazinerespiration

-1.173

Valinomycin0.5-10 uM Valinomycinrespiration

0.492

ZnSO42 mM ZnSO4respiration

1.044

menadione6-10 ug/mL Menadionerespiration

0.304

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.267

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.250

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.028

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.080

NRP_1Non-replicating persistence stage 1dosRassociated

0.379

Amp0.2mg/mL AmpicillincellWall

0.040

Cephalexin20-100 ug/mL CephalexincellWall

0.417

Cerulenin0.32-5 ug/mL CerulenincellWall

0.207

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.435

EMB10-20 ug/mL EthambutolcellWall

0.791

Eta12-40 ug/mL EthionamidecellWall

0.149

INH0.2-0.4 ug/mL IsoniazidcellWall

0.561

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.482

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.602

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.097

BZA0.12 mg/mL BenzamidearomaticAmides

-0.261

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.645

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.820

H2O24 mM hydrogen peroxideDNAdamaging

0.085

Levo10 ug/mL LevofloxacinDNAdamaging

-0.882

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.783

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.590

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.879

UVUV-irradiationDNAdamaging

-0.439

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.343

Antimycin12.5-50 ug/mL Antimycin A?

0.262

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.432

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.035

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.096

PA8240.2-2 ug/mL PA-824?

0.226

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.005

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.437

Verapamil50 uM Verapamil?

0.170

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.230

methoxatin10-20 ug/mL Methoxatin?